These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12164087)

  • 1. The changes in cardiac dimensions and function in patients with end stage renal disease undergoing hemodialysis.
    Lee DW; Kim YB; An SJ; Jung YS; Kwak IS; Shin YW; Rha HY
    Korean J Intern Med; 2002 Jun; 17(2):107-13. PubMed ID: 12164087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac consequences of renal transplantation changes in left ventricular morphology.
    Alvares S; Mota C; Soares L; Henriques C; Pereira E; Sarmento AM; Lima CA
    Rev Port Cardiol; 1998 Feb; 17(2):145-52. PubMed ID: 9587210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Left ventricular geometric patterns and cardiac function in patients with chronic renal failure undergoing hemodialysis].
    Manes MT; Gagliardi M; Misuraca G; Rossi S; Chiatto M
    Monaldi Arch Chest Dis; 2005 Mar; 64(1):27-32. PubMed ID: 16128161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry.
    Wang H; Liu J; Yao XD; Li J; Yang Y; Cao TS; Yang B
    Nephrol Dial Transplant; 2012 Dec; 27(12):4422-9. PubMed ID: 22561582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysis.
    Sato A; Funder JW; Saruta T
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):867-73. PubMed ID: 10509543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Fukukda T; Okino K; Yamamoto N; Nakamura N; Yoshikawa T; Takahashi H; Ono T
    J Nephrol; 2003; 16(5):641-9. PubMed ID: 14733409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of the cardiac architectures and functions for chronic hemodialysis patients with dry weight determined by echocardiography.
    Chang ST; Chen CC; Chen CL; Cheng HW; Chung CM; Yang TY
    Blood Purif; 2004; 22(4):351-9. PubMed ID: 15297785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy.
    Foley RN; Parfrey PS; Morgan J; Barré PE; Campbell P; Cartier P; Coyle D; Fine A; Handa P; Kingma I; Lau CY; Levin A; Mendelssohn D; Muirhead N; Murphy B; Plante RK; Posen G; Wells GA
    Kidney Int; 2000 Sep; 58(3):1325-35. PubMed ID: 10972697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
    Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
    Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?
    Gunal AI; Kirciman E; Guler M; Yavuzkir M; Celiker H
    Ren Fail; 2004 Jul; 26(4):405-9. PubMed ID: 15462109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate variability, left ventricular functions, and cardiac autonomic neuropathy in patients undergoing chronic hemodialysis.
    Karayaylali I; San M; Kudaiberdieva G; Niyazova-Karben Z; Seyrek N; Balal M; Paydas S; Sagliker Y
    Ren Fail; 2003 Sep; 25(5):845-53. PubMed ID: 14575292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic evaluation of the effect of hemodialysis on cardiac size and function in patients with end-stage renal disease.
    Vaziri ND; Prakash R
    Am J Med Sci; 1979; 278(3):201-6. PubMed ID: 161478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized heart failure therapy and complete anemia correction on left-ventricular hypertrophy in nondiabetic and diabetic patients undergoing hemodialysis.
    Hampl H; Hennig L; Rosenberger C; Gogoll L; Riedel E; Scherhag A
    Kidney Blood Press Res; 2005; 28(5-6):353-62. PubMed ID: 16534231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diastolic dysfunction in asymptomatic hemodialysis patients in the light of the current echocardiographic guidelines.
    Malik J; Kudlicka J; Valerianova A; Kovarova L; Kmentova T; Lachmanova J
    Int J Cardiovasc Imaging; 2019 Feb; 35(2):313-317. PubMed ID: 30815807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Hemodialysis on Global and Regional Cardiac Function in Children With End-stage Renal Disease.
    Amoozgar H; Naghshzan A; Basiratnia M; Ahmadipoor M
    Iran J Kidney Dis; 2018 Jan; 12(1):48-52. PubMed ID: 29421777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular morphology in chronic renal failure by echocardiography.
    Raj DS; D'Mello S; Somiah S; Sheeba SD; Mani K
    Ren Fail; 1997 Nov; 19(6):799-806. PubMed ID: 9415937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of imidapril on left ventricular mass in chronic hemodialysis patients.
    Matsumoto N; Ishimitsu T; Okamura A; Seta H; Takahashi M; Matsuoka H
    Hypertens Res; 2006 Apr; 29(4):253-60. PubMed ID: 16778332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis.
    Kim BS; Jeon DS; Shin MJ; Kim YO; Song HC; Lee SH; Kim SY; Choi EJ; Chang YS; Bang BK
    Am J Nephrol; 2005; 25(3):189-95. PubMed ID: 15863980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.